Stocks · Korea 377740 KOSPI

BioNote

4,700원 +1.29% Market cap 4,789억 2026-10-07 close
Data as of 2026-10-07 · Linked from 7 pages
An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER—
PBR0.31x
EPS0 KRW
BPS15,047 KRW
ROE-3.26%
DPS228 KRW

Returns and 52-week range

1W+0.97%
1M-2.08%
3M+0.21%
6M-9.09%
1Y-24.32%
YTD-14.86%
52W high6,260원
52W low4,050원
From 52W high-24.92%

Financial results (consolidated)

PeriodRevenueOperating incomeNet incomeOP margin
20224,797억2,954억3,078억61.6%
2023901억-470억-205억-52.2%
20241,028억122억553억11.9%
20251,183억167억-875억14.1%
Quarterly
2024 4Q247억25억553억10.3%
2025 1Q284억47억40억16.5%
2025 2Q324억63억845억19.6%
2025 3Q295억48억179억16.4%
2025 4Q280억8억-1,940억3.0%
2026 1Q326억63억413억19.5%

Company

CEO조병기
Founded2003-03-28
Fiscal year end12
Address: 경기도 화성시 삼성1로4길 22

Peers in the same sector

CompanyMarket capP/EP/B1M
로킷헬스케어4,867억—37.70+9.88%
일동제약4,686억15.721.89-1.85%
메디톡스4,926억28.471.05-2.60%
티앤엘4,588억11.942.25-2.39%
HLB생명과학5,102억—1.72+59.13%
오름테라퓨틱4,481억—3.34-62.20%

Recent filings

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.